Toggle navigation
Home
Search
Services
Blog
Contact
About
Assay Development and Initial Pharmacology Studies with SMA-491
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Climate impact on coastal ecosystem methylmercury: human exposure implications
Pathogenomics of Chlamydial Infection
Collagenase degradation in extracellular matrix in aging
Genetic Analysis of Centriole Duplication and Function
Human Immature Megakaryocytes
Recently added grants:
Sphingosine-1-phosphate and cryptococcosis
Structural Vaccinology and Design of Novel Imunogens for Malaria Vaccine Development
Role of B cell activating factor in non-infectious complications of common variable immunodeficiency
Molecular Signatures of Early-Onset Neonatal Sepsis in Umbilical Cord Blood
Epigenetic reprogramming of the malaria parasite
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM52207-10-0-2
Application #
7571114
Study Section
Project Start
2004-12-15
Project End
2009-12-14
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
/ University of Alabama Birmingham
$244,166
NIH 2007
N01 CA
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
Hill, Donald /
$233,463
NIH 2007
N01 CA
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
/
NIH 2007
N01 CA
Assay Development and Initial Pharmacology Studies with SMA-491
/
NIH 2007
N01 CA
/
Comments
Be the first to comment on this grant